News about 'TB News'

Dr. Bill Bishai DURBAN, SOUTH AFRICA (May 26, 2010) – The University of KwaZulu-Natal (UKZN) and the Howard Hughes Medical Institute today announced the appointment of William R. Bishai, M.D., Ph.D., as the first permanent director of the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K...

Dr Klaus M Leisinger, President and Managing Director of the Novartis Foundation for Sustainable Development, and Dr Hiro Nakatani, WHO Assistant Director-General Dr Klaus M Leisinger, President and Managing Director of the Novartis Foundation for Sustainable Development , and Dr Hiro Nakatani, WHO...

Global tuberculosis drug development pipeline: the need and the reality by Zhenkun Ma, Christian Lienhardt, Helen McIlleron, Andrew J Nunn, Xiexiu Wang Today, The Lancet published a series of articles on tuberculosis, which highlights the continued devastating global impact of this disease, the...

This post originally appeared on SciDev.net The patent pool may boost research into neglected diseases, such as guinea worm infection. CDC PHIL (8224) by Linda Nordling 10 May 2010 [CAPE TOWN] An industry-led ‘patent pool’, set up last year to target neglected diseases, has finally yielded some...

Grand Challenges Canada's Chief Executive Officer (CEO) Dr. Peter A. Singer looks on as Canada's Finance Minister Jim Flaherty (R) holds a microscope Dear Colleagues, It is a great pleasure to announce the launch of Grand Challenges Canada / Grands Défis Canada – an innovative organization that...

Stop TB Partnership The Stop TB Partnership’s TB REACH initiative today announced the recipients of its first wave of grants to organizations that will engage in innovative approaches to increasing detection of tuberculosis (TB). Thirty applicants from 19 countries will together receive US$ 18.4...

isoniazid structure Over the last month, a few reports about new positive TB cases have surfaced from FL, involving students at a couple of high schools and at a college. Information was not made available as to how the original infected TB individuals contracted TB. Furthermore, it is not clear...

New research to speed TB drugs to those who need it most New York and Bangalore, India, May 3, 2010 The TB Alliance and AstraZeneca announced today at the 2010 BIO International Convention that they have entered into a research collaboration agreement to accelerate the discovery, development and...

We first read this post at FierceBiotech.com . New drugs are needed to combat MDR-TB HAYWARD, Calif. and SHANGHAI, April 6 /PRNewswire/ — MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor...

This post originally appeared at http://www.news25.us/Global/story.asp?S=12380174 Purdue Chao Center Purdue drug maker closing its doors after 5 years Associated Press – April 27, 2010 4:14 AM ET WEST LAFAYETTE, Ind. (AP) – An Indiana drug maker that’s North America’s sole manufacturer of a...

How much does the nose know about TB? In a post a few weeks ago , we highlighted HeroRats , African-pouch rats, and their use for TB diagnoses. As described in that article, these rats are trained to distinguish positive TB samples verses negative TB samples presumably due to the release of...

Stop TB Partnership The latest issue no.10 of Stop-TB News Monitor, for the period, 23-26 April 2010, is available online at: http://stoptb.citizen-news.org/2010/04/cns-stop-tb-news-monitor-23-26-april.html CNS Stop-TB News Monitor provides a snapshot of five major news pieces on tuberculosis (TB)...

World Health Organization The World Health Organization’s Stop TB Department has published the fourth edition of Treatment of Tuberculosis: Guidelines. The guidelines contain a number of new recommendations, including a call to discontinue regimens based on just two months of rifampicin (2HRZE/6HE...

Despite the massive need for new TB drugs, the commercial viability of the TB drug market has long been viewed as questionable at best. Reports suggest that there is a substantial market that will grow year-over-year, though there is no firm conclusion about its commercial viability. The first...

IJTLD The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union). The IJTLD is the reference for clinical research and epidemiological studies on tuberculosis. It is also the only peer-...